Canopy Growth (TSX:WEED): Is This Stock the Ultimate Long-Term Bet?

Is Canopy Growth Corp (TSX:WEED)(NYSE:CGC) stock a good investment after the recent pullback?

| More on:

Cannabis investors have been on a roller-coaster ride in the last year. Just before Canada legalized cannabis consumption for recreational use, cannabis stocks were trading close to all-time highs. Since then, markets have been choppy, and investors have experienced extreme volatility.

Shares of Canopy Growth (TSX:WEED)(NYSE:CGC) have mirrored the markets. The stock was trading $76.68 per share back in October 2018 and has lost 43.1% in market value since then.

So, is it time for Canopy Growth shares to bounce back? Well, the company has experienced a pullback recently after its CEO and founder Bruce Linton was dismissed by the board of directors. Linton had built Canopy Growth to a $20 billion giant. But the board was unimpressed by Canopy’s piling losses.

The cannabis industry has also failed to gain investor confidence, and several experts have raised questions about corporate governance in this business. The recent scandal of CannTrust has exasperated these concerns. The Canadian Marijuana Index too is down over 30% since April this year.

Are negative profits a huge concern for Canopy Growth?

Canopy Growth has seen a stellar rise in revenue over the years. Its sales have risen from $40 million in fiscal 2017 (year ended in March) to $78 million in 2018 and $253 million in 2019. Analysts now estimate sales to reach $729 million in 2020, $1.32 billion in 2022, and $2.13 billion in 2023. This would imply an annual growth rate of over 100%.

But Canopy has failed to improve the bottom line, and this has left investors unhappy. Canopy Growth’s losses have increased over time. The company posted a net loss of $17 million in 2017. This rose to $70 million in 2018 and a staggering $685 million in 2019. Canopy’s profit margins will get better going forward.

Its losses will narrow to $524 million in 2020 and $76 million in 2021. Analysts expect the company to post a net profit of $309 million in 2022, indicating a healthy net margin of 14.5%.

Canopy Growth had raised $526 million via a stock issue in fiscal 2018. It also raised $5.2 billion in another stock issue in, while $600 million was raised in a debt issue in fiscal 2019. While this will dilute investor holding, stakeholders will not mind as long as Canopy Growth can continue to exponentially grow sales and expand profit margins.

The new CEO will be backed by Constellation Brands

Canopy Growth is also looking for a new CEO. There are speculations that the position will be filled in by Constellation Brands’s leadership team. Constellation Brands had invested $5 billion in Canopy Growth and has a 38% stake in the company. This is likely to boost investor confidence and will mean that Constellation Brands is all-in.

The verdict

Canopy Growth shares were overvalued when it was trading at $76 per share last year. The stock has corrected significantly and might still experience some volatility. However, the cannabis industry is a fast-growing market. Canopy Growth is a major player here and is consolidating its position in international markets. It also has a huge opportunity to grow inorganically.

If Canopy Growth can stay away from controversies and improve margins in line with estimates, this stock will generate significant investor returns. Constellation Brands is betting on Canopy Growth big time. While no one can predict when the stock bottoms out, it would be advisable to keep increasing positions on major dips.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »